Literature DB >> 9359727

Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.

J Hellman1, E M Zanzot, P M Loiselle, S F Amato, K M Black, Y Ge, J T Kurnick, H S Warren.   

Abstract

The binding of IgG in antiserum to Escherichia coli J5 to the surface of Enterobacteriaceae and to cell wall fragments released from serum-exposed bacteria was studied in a search for potentially protective epitopes other than lipopolysaccharide (LPS). IgG titers to multiple heterologous gram-negative smooth bacteria increased following incubation of the bacteria in serum and decreased following absorption with serum-exposed heterologous bacteria. IgG eluted from absorbing bacteria bound to at least three conserved bacterial outer membrane proteins (OMPs), but not LPS, as assessed by immunoblotting. The same OMPs were present in LPS-containing macromolecular cell wall fragments released by incubation of heterologous gram-negative bacteria in human serum. Part of the protection offered by J5 antiserum could be from binding of IgG to conserved OMPs at the bacterial surface or to OMPs in cell-wall fragments released from dying bacteria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359727     DOI: 10.1086/514121

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.

Authors:  J Hellman; P M Loiselle; M M Tehan; J E Allaire; L A Boyle; J T Kurnick; D M Andrews; K Sik Kim; H S Warren
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

Review 3.  Virulence and immunomodulatory roles of bacterial outer membrane vesicles.

Authors:  Terri N Ellis; Meta J Kuehn
Journal:  Microbiol Mol Biol Rev       Date:  2010-03       Impact factor: 11.056

4.  A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis.

Authors:  N A Busch; E M Zanzot; P M Loiselle; E A Carter; J E Allaire; M L Yarmush; H S Warren
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Dual orientation of the outer membrane lipoprotein Pal in Escherichia coli.

Authors:  Lea Vacca Michel; Juliana Shaw; Victoria MacPherson; David Barnard; John Bettinger; Brooke D'Arcy; Naveen Surendran; Judith Hellman; Michael E Pichichero
Journal:  Microbiology       Date:  2015-03-25       Impact factor: 2.777

6.  Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature's perfect packages.

Authors:  Lea Vacca Michel; Thomas Gaborski
Journal:  J Biol Chem       Date:  2022-09-13       Impact factor: 5.486

7.  Characterization of surface proteins of Cronobacter muytjensii using monoclonal antibodies and MALDI-TOF Mass spectrometry.

Authors:  Ziad W Jaradat; Abrar M Rashdan; Qotaiba O Ababneh; Saied A Jaradat; Arun K Bhunia
Journal:  BMC Microbiol       Date:  2011-06-25       Impact factor: 3.605

8.  Shielding Effect of Escherichia coli O-Antigen Polysaccharide on J5-Induced Cross-Reactive Antibodies.

Authors:  Pascal Rainard; Maryline Repérant-Ferter; Christophe Gitton; Pierre Germon
Journal:  mSphere       Date:  2021-01-27       Impact factor: 4.389

9.  Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form.

Authors:  Maribasappa Karched; Riikka Ihalin; Kjell Eneslätt; Deyu Zhong; Jan Oscarsson; Sun N Wai; Casey Chen; Sirkka E Asikainen
Journal:  BMC Microbiol       Date:  2008-01-28       Impact factor: 3.605

Review 10.  Analyzing the molecular mechanism of lipoprotein localization in Brucella.

Authors:  Shivani Goolab; Robyn L Roth; Henriette van Heerden; Michael C Crampton
Journal:  Front Microbiol       Date:  2015-10-28       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.